United Therapeutics
UTHR
545.00
+3.38
+0.62%
United Therapeutics
US · UTHR
#836 by market cap
Listed 1970
545.00
+3.38
+0.62%
Live - 5344 symbols - heartbeat 480s ago
· 2026-10-08 06:19
Pre-market
546.17
+0.21%
After-hours
545.00
0.00%
Overnight
546.00
+0.18%
- Market cap
- 23.38B
- P/E (TTM)i
- 19.53
- P/Bi
- 3.65
- EPSi
- 27.86
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on UTHR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
629.63 +15.5%
Price target rangecurrent 545.00
Low321.00
Avg629.63
High704.00
Buy 75%
Hold 13%
Sell 13%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | RBC Capital | -- | BUY | 677.00 |
| 2026-09-24 | Goldman Sachs | -- | SELL | 321.00 |
| 2026-09-09 | Jefferies | -- | BUY | 704.00 |
| 2026-09-02 | TD Cowen | -- | BUY | 675.00 |
| 2026-09-02 | Wells Fargo | -- | BUY | 700.00 |
| 2026-08-25 | RBC Capital | -- | BUY | 677.00 |
| 2026-08-24 | TD Cowen | -- | BUY | 675.00 |
| 2026-08-19 | Wells Fargo | -- | BUY | 700.00 |
| 2026-08-06 | Wells Fargo | -- | BUY | 700.00 |
| 2026-08-06 | H.C. Wainwright | -- | BUY | 660.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 675.00 |
| 2026-08-05 | RBC Capital | -- | BUY | 677.00 |
| 2026-07-30 | Wells Fargo | -- | BUY | 738.00 |
| 2026-07-23 | J.P. Morgan | -- | BUY | 687.00 |
| 2026-07-10 | BofA Securities | -- | HOLD | 613.00 |
| 2026-07-10 | Jefferies | -- | BUY | 714.00 |
| 2026-07-07 | RBC Capital | -- | BUY | 704.00 |
| 2026-06-29 | Leerink Partners | -- | BUY | -- |
| 2026-06-12 | Leerink Partners | -- | BUY | 700.00 |
| 2026-06-05 | TD Cowen | -- | BUY | 675.00 |
| 2026-05-29 | H.C. Wainwright | -- | BUY | 660.00 |
| 2026-05-20 | H.C. Wainwright | -- | BUY | 660.00 |
| 2026-05-19 | Jefferies | -- | BUY | 733.00 |
| 2026-05-17 | TD Cowen | -- | BUY | 675.00 |
| 2026-05-07 | Wells Fargo | -- | BUY | 738.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±6.41% | +0.06% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±7.62% | +4.29% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±9.13% | +13.03% (beat) |
| 2025/Q3 | 2025-10-29 | -- | ±9.93% | +9.63% (in line) |
| 2025/Q2 | 2025-07-30 | -- | ±9.47% | -5.25% (in line) |
| 2025/Q1 | 2025-04-30 | -- | ±7.44% | +0.77% (in line) |
| 2024/Q4 | 2025-02-26 | -- | ±9.10% | -10.80% (beat) |
| 2024/Q3 | 2024-10-30 | -- | ±7.37% | +2.44% (in line) |
| 2024/Q2 | 2024-07-31 | -- | ±7.97% | -7.18% (in line) |
| 2024/Q1 | 2024-05-01 | -- | ±8.20% | +8.88% (beat) |
| 2023/Q4 | 2024-02-21 | -- | ±8.78% | +2.34% (in line) |
| 2023/Q3 | 2023-11-01 | -- | ±7.25% | +0.55% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:19:20 · For reference only, not investment advice and not tailored to your situation.